Evidence map›Paper›PMID 21269678›Full record

ReviewLancet (London, England)2011

Emerging infectious diseases in southeast Asia: regional challenges to control.

Richard J Coker, Benjamin M Hunter, James W Rudge, Marco Liverani, Piya Hanvoravongchai

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 214 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Measurement in the study of human exposure to animal feces: A systematic review and audit.International journal of hygiene and environmental health · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Molecular xenosurveillance ofMicrobiology spectrum · 2025
    Article
  19. Article
  20. Article

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Richard J CokerCommunicable Diseases Policy Research Group, London School of Hygiene and Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. richard.coker@lshtm.ac.uk
Benjamin M Hunter
James W Rudge
Marco Liverani
Piya Hanvoravongchai

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Southeast Asia is a hotspot for emerging infectious diseases, including those with pandemic potential. Emerging infectious diseases have exacted heavy public health and economic tolls. Severe acute respiratory syndrome rapidly decimated the region's tourist industry. Influenza A H5N1 has had a profound effect on the poultry industry. The reasons why southeast Asia is at risk from emerging infectious diseases are complex. The region is home to dynamic systems in which biological, social, ecological, and technological processes interconnect in ways that enable microbes to exploit new ecological niches. These processes include population growth and movement, urbanisation, changes in food production, agriculture and land use, water and sanitation, and the effect of health systems through generation of drug resistance. Southeast Asia is home to about 600 million people residing in countries as diverse as Singapore, a city state with a gross domestic product (GDP) of US$37,500 per head, and Laos, until recently an overwhelmingly rural economy, with a GDP of US$890 per head. The regional challenges in control of emerging infectious diseases are formidable and range from influencing the factors that drive disease emergence, to making surveillance systems fit for purpose, and ensuring that regional governance mechanisms work effectively to improve control interventions.

Indexed as

AnimalsAsia, SoutheasternCommunicable Diseases, EmergingConservation of Natural ResourcesCost of IllnessDeveloping CountriesDrug Resistance, MicrobialHumansInfluenza A Virus, H5N1 SubtypeInfluenza, HumanLivestockPopulation SurveillanceSevere Acute Respiratory SyndromeUrbanizationZoonoses

Identifiers

PMID21269678
PMCPMC7159088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.